Welcome to our dedicated page for Owlet SEC filings (Ticker: OWLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Owlet, Inc. (NYSE: OWLT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI‑assisted summaries to help interpret complex documents. As a pediatric health platform offering FDA‑cleared medical and consumer pediatric wearables and connected cameras, Owlet’s filings give investors insight into how it manages growth, regulation, financing, and governance.
In Owlet’s Form 8‑K filings, readers can find information on quarterly financial results, equity offerings, warrant exchanges, executive leadership changes, corporate governance amendments, and settlements related to historical product matters. Recent 8‑Ks describe preliminary and final financial results, an underwriting agreement for a follow‑on equity offering, a warrant‑for‑share exchange approved by stockholders, and updates to the company’s certificate of incorporation and incentive award plan.
Definitive proxy statements (such as the DEF 14A) outline board structure, director elections, equity compensation plans, auditor ratification, and proposals requiring stockholder approval. These documents also discuss topics like officer exculpation provisions, stock issuance approvals, and the mechanics of Owlet’s annual meeting, giving a detailed view of the company’s governance framework.
On this page, you can monitor new 10‑K annual reports and 10‑Q quarterly reports as they are filed with EDGAR, along with any additional 8‑Ks and amendments. Stock Titan’s AI features summarize key sections, highlight risk factor themes, capital structure changes, and major contract disclosures, and surface notable items such as warrant exchanges or derivative litigation settlements. You can also review insider‑related information disclosed in connection with equity plans and exchanges, and track how Owlet describes regulatory, reimbursement, and market risks associated with its pediatric monitoring devices and digital health services.
Owlet, Inc. director Laura Durr reported receiving a grant of 18,996 restricted stock units (RSUs) of Owlet common stock as compensation. Each RSU converts into one share upon vesting, with all RSUs vesting on the earlier of the first anniversary of the grant date or immediately before the next annual stockholder meeting, subject to her continued service. The filing notes the transaction was reported late due to an administrative oversight. Following this award, Durr directly holds 100,669 shares of Owlet common stock.
Gonzales Melissa reported acquisition or exercise transactions in this Form 4 filing.
Owlet, Inc. director Melissa Gonzales received an equity award of 18,996 restricted stock units (RSUs) of common stock. The RSUs entitle her to one share of Owlet common stock for each unit as they vest, with no cash paid per share.
The RSUs will fully vest on the earlier of the first anniversary of the grant date or immediately before Owlet’s next annual stockholders’ meeting, as long as she continues serving the company through that date. After this grant, she holds 87,905 shares of Owlet common stock directly. The Form 4 notes that this transaction was reported late because of an administrative oversight.
Kim John C. reported acquisition or exercise transactions in this Form 4 filing.
Owlet, Inc. director John C. Kim received an equity grant of 18,996 restricted stock units (RSUs). Each RSU entitles him to one share of Owlet common stock upon vesting, at no purchase price. After this grant, he holds 252,026 shares/RSUs in total.
The RSUs will fully vest on the earlier of the first anniversary of the grant date or immediately before Owlet’s next annual stockholder meeting, as long as he continues to serve the company through that date. The filing notes that this transaction was reported late due to an administrative oversight.
Owlet, Inc. former President & CEO Jonathan Harris reported a mix of stock sales and equity awards in Owlet common stock. On February 26, 2026, he sold 12,676 shares at $11.50 per share in an automatic, non-discretionary transaction to cover taxes and fees tied to vesting restricted stock units. That same day, he received 41,666 shares at no cost through stock awards, including performance-based RSUs linked to cumulative net revenue goals through December 31, 2028. The filing also lists several smaller open-market sales between July 2025 and February 2026. After these transactions, Harris directly holds 352,012 shares of Owlet common stock, with a net sale of 26,750 shares across the reported period.
Owlet, Inc. filed Amendment No. 1 to its annual report to add the previously omitted Part III sections covering directors, executive officers, executive compensation, ownership, related-party transactions and auditor fees. The amendment does not change the company’s 2025 financial statements.
The filing details a refreshed board and audit & risk committee, 2025 pay for CEO Kurt Workman, former CEO Jonathan Harris and CFO Amanda Crawford, and new performance-based RSU grants tied to cumulative net revenue through 2028. It also outlines a change-in-control severance plan, major holders’ combined voting power of over 35%, related-party financings and warrant exchanges, and 2025 audit fees of $1,776,800 paid to PwC.
Owlet, Inc. President & CEO Kurt Workman reported receiving a grant of 850,000 shares of Common Stock on April 28, 2026 at $0.00 per share, bringing his directly held stake to 1,232,080 shares.
The Form 4 also lists prior 2025 activity, including open-market sales totaling 52,233 shares at prices between $4.26 and $8.46, after which he still held over 380,000 shares. Some shares were automatically sold in non-discretionary transactions to cover taxes and fees tied to vesting of RSUs, and his balance includes shares acquired through Owlet's Employee Stock Purchase Plan and performance-based RSU awards.
Owlet, Inc. Chief Financial Officer Amanda Crawford reported a mix of stock sales and equity awards in Owlet common stock. On February 27, 2026, she sold 6,892 shares at $11.50 per share in a non-discretionary transaction to cover taxes and fees related to vesting restricted stock units, and held 212,800 shares afterward.
On February 25, 2026, she received a grant of 20,833 shares at no cost as part of her compensation. Footnotes also describe additional time-based and performance-based RSUs that convert into one share each upon vesting, tied to service and cumulative net revenue goals through December 31, 2028.
The filing notes one transaction was reported late due to an administrative oversight, and shows no remaining derivative securities after these updates.
Owlet, Inc. Chief Financial Officer Amanda Crawford reported a small, non-market transaction related to equity compensation. On April 15, 2026, 141 shares of Owlet common stock were withheld at $5.66 per share to cover tax obligations triggered by vesting of restricted stock units. After this tax-withholding disposition, she directly holds 159,679 shares of common stock.
Owlet, Inc. Chief Financial Officer Amanda Crawford received a grant of 32,032 shares of common stock on April 3, 2026. According to the disclosure, these shares were issued in lieu of her earned 2025 annual incentive bonus, with a cash value of $157,531, based on the volume weighted average price of the stock over five prior trading days.
On the same date, 9,242 shares of common stock were withheld to satisfy tax obligations tied to restricted stock units that vested in connection with this award. After these compensation-related transactions and tax withholding, Crawford directly holds 159,820 shares of Owlet common stock.
Owlet, Inc. announced that its Board appointed co-founder Kurt Workman as President and Chief Executive Officer, effective April 6, 2026, succeeding Jonathan Harris. Workman will also serve as the Company’s principal executive officer and will remain on the Board, but will no longer be Executive Chairman.
In connection with Harris’s separation, Owlet entered into a Separation and Release Agreement providing 12 months of continued base salary, a prorated 2026 bonus based on actual performance, and accelerated vesting of all his outstanding equity awards.
Owlet also signed an Employment Offer Letter with Workman, setting an annual base salary of $500,000 and an annual cash performance bonus target equal to 70% of base salary, subject to Company and individual performance. As a Tier 1 participant in the Executive Change in Control Severance Plan, if terminated without Cause or he resigns for Good Reason, Workman may receive 12 months of base salary, a prorated bonus for the year of termination based on actual results and days worked, and immediate vesting of all unvested equity awards.